|
|
|
Volumn 13, Issue 1, 2010, Pages 30-37
|
|
Current drug patenting for retinal diseases: Beyond VEGF inhibitors
a
|
|
Author keywords
Diabetic retinopathy; Macular degeneration; Patent; Retinal disease; Retinopathy of prematurity
|
|
Indexed keywords
1 AMINOMETHYL 5,6 DIHYDROXY 3 PHENYLISOCHROMAN;
3 (1 ADAMANTYL) 1 AMINOMETHYL 3,4 DIHYDRO 5,6 DIHYDROXY 1H 2 BENZOPYRAN;
4 (2,6 DICHLORO 4 PYRIDINYL) 1 (1,3 DIMETHYL 4 ISOPROPYL 1H PYRAZOLO[3,4 B]PYRIDIN 6 YL)SEMICARBAZIDE;
AMYLOID BETA PROTEIN;
BEVACIZUMAB;
COMPLEMENT COMPONENT C3B;
COMPLEMENT COMPONENT C3B RECEPTOR;
COMPLEMENT COMPONENT C4B;
COMPLEMENT COMPONENT C5A;
COMPLEMENT COMPONENT C5B;
GLATIRAMER;
HEME OXYGENASE 1;
HEME OXYGENASE 2;
HYPOXIA INDUCIBLE FACTOR 1;
MATRIX METALLOPROTEINASE;
MIDOSTAURIN;
MONOCLONAL ANTIBODY;
PRAMIPEXOLE;
PROTEIN KINASE C;
ROPINIROLE;
RUBOXISTAURIN;
SAFINAMIDE;
SEMICARBAZIDE;
SMALL INTERFERING RNA;
SONEPCIZUMAB;
SPHINGOSINE 1 PHOSPHATE RECEPTOR;
SURAMIN;
THIOFLAVINE;
TRIAMCINOLONE ACETONIDE;
UNCLASSIFIED DRUG;
VASCULOTROPIN;
VASCULOTROPIN INHIBITOR;
AFRICAN TRYPANOSOMIASIS;
ALZHEIMER DISEASE;
CLINICAL TRIAL;
CORNEA NEOVASCULARIZATION;
DIABETIC RETINOPATHY;
ELECTRORETINOGRAM;
EYE DISEASE;
GENETIC ASSOCIATION;
HUMAN;
IN VITRO STUDY;
ONCHOCERCIASIS;
PHOTORECEPTOR;
PREDICTION;
RETINA DISEASE;
RETINA MACULA AGE RELATED DEGENERATION;
RETINA NEOVASCULARIZATION;
REVIEW;
SIGNAL TRANSDUCTION;
SINGLE NUCLEOTIDE POLYMORPHISM;
ANIMALS;
BIOLOGICAL MARKERS;
DIABETIC RETINOPATHY;
DRUG DESIGN;
HUMANS;
MACULAR DEGENERATION;
PATENTS AS TOPIC;
RETINAL DISEASES;
RISK FACTORS;
|
|
EID: 73649084081
PISSN: 13697056
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (2)
|
|
References (0)
|
